These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 2782249)
1. Intravenous amiodarone for the rapid treatment of life-threatening ventricular arrhythmias in critically ill patients with coronary artery disease. Ochi RP; Goldenberg IF; Almquist A; Pritzker M; Milstein S; Pedersen W; Gobel FL; Benditt DG Am J Cardiol; 1989 Sep; 64(10):599-603. PubMed ID: 2782249 [TBL] [Abstract][Full Text] [Related]
2. Oral amiodarone loading for the rapid treatment of frequent, refractory, sustained ventricular arrhythmias associated with coronary artery disease. Russo AM; Beauregard LM; Waxman HL Am J Cardiol; 1993 Dec; 72(18):1395-9. PubMed ID: 8256733 [TBL] [Abstract][Full Text] [Related]
3. Intravenous amiodarone in the treatment of refractory life-threatening cardiac arrhythmias in the critically ill patient. Leak D Am Heart J; 1986 Mar; 111(3):456-62. PubMed ID: 3953353 [TBL] [Abstract][Full Text] [Related]
4. Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Group. Kowey PR; Levine JH; Herre JM; Pacifico A; Lindsay BD; Plumb VJ; Janosik DL; Kopelman HA; Scheinman MM Circulation; 1995 Dec; 92(11):3255-63. PubMed ID: 7586312 [TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy of intravenous amiodarone in the short term treatment of recurrent sustained ventricular tachycardia and ventricular fibrillation. Schützenberger W; Leisch F; Kerschner K; Harringer W; Herbinger W Br Heart J; 1989 Nov; 62(5):367-71. PubMed ID: 2590589 [TBL] [Abstract][Full Text] [Related]
6. Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. The Intravenous Amiodarone Multicenter Investigators Group. Scheinman MM; Levine JH; Cannom DS; Friehling T; Kopelman HA; Chilson DA; Platia EV; Wilber DJ; Kowey PR Circulation; 1995 Dec; 92(11):3264-72. PubMed ID: 7586313 [TBL] [Abstract][Full Text] [Related]
7. Intravenous amiodarone for short-term treatment of refractory ventricular tachycardia or fibrillation. Nalos PC; Ismail Y; Pappas JM; Nyitray W; DonMichael TA Am Heart J; 1991 Dec; 122(6):1629-32. PubMed ID: 1957758 [TBL] [Abstract][Full Text] [Related]
9. Amiodarone and sustained ventricular arrhythmias: statistical evidence of drug effectiveness. Flaker GC; Alpert MA; Webel RR; Ruder MA; Sanfelippo JF; Tsutakawa RK Am Heart J; 1985 Aug; 110(2):371-6. PubMed ID: 4025112 [TBL] [Abstract][Full Text] [Related]
10. An overview of antiarrhythmic drug management of electrical storm. Kowey PR Can J Cardiol; 1996 Apr; 12 Suppl B():3B-8B; discussion 27B-28B. PubMed ID: 8616726 [TBL] [Abstract][Full Text] [Related]
11. Intravenous amiodarone for life-threatening tachyarrhythmias in children and young adults. Perry JC; Knilans TK; Marlow D; Denfield SW; Fenrich AL; Friedman RA J Am Coll Cardiol; 1993 Jul; 22(1):95-8. PubMed ID: 8509571 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness and safety of intravenous amiodarone in drug-resistant tachyarrhythmias of children. Celiker A; Ceviz N; Ozme S Acta Paediatr Jpn; 1998 Dec; 40(6):567-72. PubMed ID: 9893292 [TBL] [Abstract][Full Text] [Related]
13. Amiodarone in patients with recurrent sustained ventricular tachyarrhythmias: results of programmed electrical stimulation and long-term clinical outcome in chronic treatment. Schmitt C; Brachmann J; Waldecker B; Rizos I; Senges J; Kübler W Am Heart J; 1987 Aug; 114(2):279-83. PubMed ID: 3604883 [TBL] [Abstract][Full Text] [Related]
14. Usefulness of electrophysiologic testing in evaluation of amiodarone therapy for sustained ventricular tachyarrhythmias associated with coronary heart disease. Horowitz LN; Greenspan AM; Spielman SR; Webb CR; Morganroth J; Rotmensch H; Sokoloff NM; Rae AP; Segal BL; Kay HR Am J Cardiol; 1985 Feb; 55(4):367-71. PubMed ID: 3969870 [TBL] [Abstract][Full Text] [Related]
15. High incidence of clinical and subclinical toxicity associated with amiodarone treatment of refractory tachyarrhythmias. Anastasiou-Nana MI; Anderson JL; Nanas JN; Lutz JR; Smith RA; Anderson KP; Crapo RO; Call NB Can J Cardiol; 1986; 2(3):138-45. PubMed ID: 2941121 [TBL] [Abstract][Full Text] [Related]
16. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study. Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357 [TBL] [Abstract][Full Text] [Related]
17. Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias. Clemo HF; Wood MA; Gilligan DM; Ellenbogen KA Am J Cardiol; 1998 Mar; 81(5):594-8. PubMed ID: 9514456 [TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of postmyocardial infarction patients with ventricular tachycardia or ventricular fibrillation treated with amiodarone. Strasberg B; Kusniec J; Zlotikamien B; Mager A; Sclarovsky S Am J Cardiol; 1990 Sep; 66(7):673-8. PubMed ID: 2399883 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of malignant ventricular tachyarrhythmia with amiodarone: comparison of empirical administration and administration guided by Holter or ventricular stimulation. Results of the parallel test]. Raviele A; Di Pede F; Gasparini G; Zanocco A; Delise P; Bonso A; D'Este D; Piccolo E G Ital Cardiol; 1991 Mar; 21(3):259-69. PubMed ID: 1894120 [TBL] [Abstract][Full Text] [Related]